MRes in Clinical Research
Choose your path...
The MRes in Clinical Research is an umbrella course comprising of four pathways. All of these pathways provide teaching and research on a different specialist area of Clinical Research:
Applications are currently being accepted for 2013 entry – please apply online.
MRes Cellular Pathology
Provides training for laboratory or clinical histologists and cytologists, whether medically or biomedically qualified.
MRes Clinical Research Design and Management
Caters for nurses and allied healthcare professionals.
MRes in Human Nutrition
Designed for health care professionals and scientists with interest in nutrition research.
MRes in Translational Medicine
Designed for medics and basic scientists.
Course structure
The format and assessment method for all 4 pathways, along with the first three modules are the same for all students. The final module offered is a specialist module for each pathway and the research project provides the opportunity for students to carry out research within their chosen area.
Links with Employers
Imperial College works closely with employers and industry, including Industrial Advisory Panels to design Master’s courses which provide graduates with technical knowledge, expertise and transferable skills and to encourage students to take internships and placements. All Master’s courses are designed with employer needs in mind with some Master’s courses accredited by Professional, Statutory and Regulatory Bodies. Most Master’s courses offer an opportunity to carry out research projects in industry.
Supporting and developing skills in clinical research and in particular, Experimental and Translational Medicine, have been highlighted in government reports (e.g. From the Office of Life Sciences 2009) as a priority for investment. It is widely recognised that these skills are essential to the development of new treatments and provide a major incentive for the pharmaceutical industry to invest in the UK when developing new medicines. The course seeks to equip individuals to fill the roles that Academia, the NHS and Pharma will need to fulfill its healthcare agenda.
